Literature DB >> 19737523

A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure.

Vijay K Yadav1, Franck Oury, Nina Suda, Zhong-Wu Liu, Xiao-Bing Gao, Cyrille Confavreux, Kristen C Klemenhagen, Kenji F Tanaka, Jay A Gingrich, X Edward Guo, Laurence H Tecott, J John Mann, Rene Hen, Tamas L Horvath, Gerard Karsenty.   

Abstract

Leptin inhibition of bone mass accrual requires the integrity of specific hypothalamic neurons but not expression of its receptor on these neurons. The same is true for its regulation of appetite and energy expenditure. This suggests that leptin acts elsewhere in the brain to achieve these three functions. We show here that brainstem-derived serotonin (BDS) favors bone mass accrual following its binding to Htr2c receptors on ventromedial hypothalamic neurons and appetite via Htr1a and 2b receptors on arcuate neurons. Leptin inhibits these functions and increases energy expenditure because it reduces serotonin synthesis and firing of serotonergic neurons. Accordingly, while abrogating BDS synthesis corrects the bone, appetite and energy expenditure phenotypes caused by leptin deficiency, inactivation of the leptin receptor in serotonergic neurons recapitulates them fully. This study modifies the map of leptin signaling in the brain and identifies a molecular basis for the common regulation of bone and energy metabolisms. For a video summary of this article, see the PaperFlick file with the Supplemental Data available online.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19737523      PMCID: PMC2768582          DOI: 10.1016/j.cell.2009.06.051

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  48 in total

Review 1.  Obesity and the regulation of energy balance.

Authors:  B M Spiegelman; J S Flier
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

2.  Hypocretins (orexins) regulate serotonin neurons in the dorsal raphe nucleus by excitatory direct and inhibitory indirect actions.

Authors:  Rong-Jian Liu; Anthony N van den Pol; George K Aghajanian
Journal:  J Neurosci       Date:  2002-11-01       Impact factor: 6.167

3.  Synthesis of serotonin by a second tryptophan hydroxylase isoform.

Authors:  Diego J Walther; Jens-Uwe Peter; Saleh Bashammakh; Heide Hörtnagl; Mechthild Voits; Heidrun Fink; Michael Bader
Journal:  Science       Date:  2003-01-03       Impact factor: 47.728

4.  Leptin regulates bone formation via the sympathetic nervous system.

Authors:  Shu Takeda; Florent Elefteriou; Regis Levasseur; Xiuyun Liu; Liping Zhao; Keith L Parker; Dawna Armstrong; Patricia Ducy; Gerard Karsenty
Journal:  Cell       Date:  2002-11-01       Impact factor: 41.582

5.  Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass.

Authors:  P Ducy; M Amling; S Takeda; M Priemel; A F Schilling; F T Beil; J Shen; C Vinson; J M Rueger; G Karsenty
Journal:  Cell       Date:  2000-01-21       Impact factor: 41.582

6.  Dissociation of the neuronal regulation of bone mass and energy metabolism by leptin in vivo.

Authors:  Yu Shi; Vijay K Yadav; Nina Suda; X Sherry Liu; X Edward Guo; Martin G Myers; Gerard Karsenty
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-11       Impact factor: 11.205

7.  Selective deletion of leptin receptor in neurons leads to obesity.

Authors:  P Cohen; C Zhao; X Cai; J M Montez; S C Rohani; P Feinstein; P Mombaerts; J M Friedman
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

8.  Activation of central melanocortin pathways by fenfluramine.

Authors:  Lora K Heisler; Michael A Cowley; Laurence H Tecott; Wei Fan; Malcolm J Low; James L Smart; Marcelo Rubinstein; Jeffrey B Tatro; Jacob N Marcus; Henne Holstege; Charlotte E Lee; Roger D Cone; Joel K Elmquist
Journal:  Science       Date:  2002-07-26       Impact factor: 47.728

9.  Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum.

Authors:  Vijay K Yadav; Je-Hwang Ryu; Nina Suda; Kenji F Tanaka; Jay A Gingrich; Günther Schütz; Francis H Glorieux; Cherie Y Chiang; Jeffrey D Zajac; Karl L Insogna; J John Mann; Rene Hen; Patricia Ducy; Gerard Karsenty
Journal:  Cell       Date:  2008-11-28       Impact factor: 41.582

Review 10.  Anatomic basis of leptin action in the hypothalamus.

Authors:  J K Elmquist
Journal:  Front Horm Res       Date:  2000       Impact factor: 2.606

View more
  256 in total

Review 1.  Building strong bones: molecular regulation of the osteoblast lineage.

Authors:  Fanxin Long
Journal:  Nat Rev Mol Cell Biol       Date:  2011-12-22       Impact factor: 94.444

Review 2.  Type 2 diabetes and bone fractures.

Authors:  Kendall F Moseley
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2012-04       Impact factor: 3.243

Review 3.  Osteoblastogenesis regulation signals in bone remodeling.

Authors:  C Zuo; Y Huang; R Bajis; M Sahih; Y-P Li; K Dai; X Zhang
Journal:  Osteoporos Int       Date:  2012-06       Impact factor: 4.507

4.  Crosstalk between the brain and bone.

Authors:  Laura Masi
Journal:  Clin Cases Miner Bone Metab       Date:  2012-05-29

Review 5.  Evolving concepts in neurogenic osteoporosis.

Authors:  Weiping Qin; William A Bauman; Christopher P Cardozo
Journal:  Curr Osteoporos Rep       Date:  2010-12       Impact factor: 5.096

6.  Physiology: The bones of contention.

Authors:  Alla Katsnelson
Journal:  Nature       Date:  2010-08-19       Impact factor: 49.962

Review 7.  Minireview: A skeleton in serotonin's closet?

Authors:  Masanobu Kawai; Clifford J Rosen
Journal:  Endocrinology       Date:  2010-07-21       Impact factor: 4.736

8.  Disruption of hypothalamic leptin signaling in mice leads to early-onset obesity, but physiological adaptations in mature animals stabilize adiposity levels.

Authors:  Laurence E Ring; Lori M Zeltser
Journal:  J Clin Invest       Date:  2010-07-01       Impact factor: 14.808

9.  Gut-derived serotonin contributes to bone deficits in colitis.

Authors:  B Lavoie; J A Roberts; M M Haag; S N Spohn; K G Margolis; K A Sharkey; J B Lian; G M Mawe
Journal:  Pharmacol Res       Date:  2018-07-17       Impact factor: 7.658

10.  Current anti-depressant use is associated with cortical bone deficits and reduced physical function in elderly women.

Authors:  Sanchita Agarwal; Carmen Germosen; Nayoung Kil; Mariana Bucovsky; Ivelisse Colon; John Williams; Elizabeth Shane; Marcella D Walker
Journal:  Bone       Date:  2020-07-27       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.